Jiangxi Synergy Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Jiangxi Synergy Pharmaceutical Co Ltd cash flow-to-debt ratio. Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of CN¥65.40 Million could theoretically repay 0% of its total liabilities (CN¥882.54 Million) in one year. Check 300636 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)
Cash flow-to-debt ratio of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025. Historical debt coverage capacity for Jiangxi Synergy Pharmaceutical Co Ltd across 14 annual periods. Check 300636 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Jiangxi Synergy Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Jiangxi Synergy Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Jiangxi Synergy Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangxi Synergy Pharmaceutical Co Ltd (300636) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥202.07 Million | CN¥955.80 Million | ▼ -25.1% |
| 2024 | 0.28x | CN¥285.19 Million | CN¥1.01 Billion | ▲ +71.4% |
| 2023 | 0.16x | CN¥163.75 Million | CN¥994.99 Million | ▼ -21.1% |
| 2022 | 0.21x | CN¥196.00 Million | CN¥939.19 Million | ▲ +61.9% |
| 2021 | 0.13x | CN¥131.34 Million | CN¥1.02 Billion | ▲ +4.9% |
| 2020 | 0.12x | CN¥80.07 Million | CN¥651.17 Million | ▲ +234.6% |
| 2019 | -0.09x | CN¥-28.27 Million | CN¥309.40 Million | ▼ -117.7% |
| 2018 | 0.52x | CN¥74.93 Million | CN¥145.46 Million | ▲ +28.9% |
| 2017 | 0.40x | CN¥34.05 Million | CN¥85.18 Million | ▼ -24.4% |
| 2016 | 0.53x | CN¥60.45 Million | CN¥114.31 Million | ▼ -32.1% |
| 2015 | 0.78x | CN¥79.42 Million | CN¥101.99 Million | ▲ +68.2% |
| 2014 | 0.46x | CN¥64.50 Million | CN¥139.28 Million | ▲ +403.1% |
| 2013 | 0.09x | CN¥14.42 Million | CN¥156.62 Million | ▲ +585.5% |
| 2012 | -0.02x | CN¥-2.72 Million | CN¥143.31 Million | — |